UT Health San Antonio

Researchers at UT San Antonio’s Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases are leading a new $2.5 million national, multi-site study to advance understanding of dementia with Lewy bodies, one of the most common and complex forms of dementia.

The study will help identify biomarkers that could improve diagnosis, accelerate research and support the development of future treatments.

This work reflects the powerful connection between discovery at UT San Antonio and care at UT Health San Antonio, bringing research and clinical expertise together to improve the future of brain health for patients and families.

Read more: https://bit.ly/4c7E6WH

Could regularly sleeping more than nine hours a night be an early sign of changes linked to Alzheimer's disease?

A new UT Health San Antonio study found that longer sleep duration was associated with higher levels of a blood biomarker tied to Alzheimer's disease, offering new insight into the earliest stages of neurodegeneration. Read more: https://bit.ly/3TpkRBk

At 75, Frank Morrill wasn't ready to slow down. After a knee injury worsened ongoing pain and instability, the activities he loved became increasingly difficult.

With guidance from Thomas DeBerardino, MD, orthopaedic surgeon at UT Health San Antonio, Frank received the MISHA knee implant, an innovative procedure designed for patients who aren't yet candidates for a total knee replacement.

Today, he's back to the life he loves.

"Essentially, I've got my knee back," Frank said. "I can dance, do yoga and chase after my grandkids again."

Read his story: https://bit.ly/4w1G4zO

Back in motion: New knee procedure helps patient return to life he loves - UT Health San Antonio At 75, Frank Morrill, a retired attorney, leads an active life filled with dance, yoga and time with his grandchildren. But in 2024, a knee injury began to limit the mobility he depended on.

The future of health care starts with education, mentorship and discovery.

Each summer, undergraduate students from across the country come to UT Health San Antonio to work alongside leading researchers and clinicians, gaining hands-on experience in laboratories, clinics and learning environments where discovery translates into better patient care.

By investing in the next generation of physicians, scientists and health professionals, we're helping strengthen the health care workforce that will make lives better across South Texas and beyond. https://bit.ly/4vhMXvz

At 75, Frank Morrill wasn't ready to slow down. After a knee injury worsened ongoing pain and instability, the activities he loved became increasingly difficult.

With guidance from Thomas DeBerardino, MD, orthopaedic surgeon at UT Health San Antonio, Frank received the MISHA knee implant, an innovative procedure designed for patients who aren't yet candidates for a total knee replacement.

Today, he's back to the life he loves.

"Essentially, I've got my knee back," Frank said. "I can dance, do yoga and chase after my grandkids again."

When a table saw accident severely injured his hand, Brian Smothers feared he might never play guitar again.

With expert surgical care, dedicated rehabilitation and months of determination, he returned to doing what he loves most.

Read Brian's story and learn how compassionate, specialized care helped him get back on stage: https://bit.ly/44kzgAT

A discovery by UT Health San Antonio researchers could help reshape the future of lupus treatment.

In a study published in Nature Communications, scientists identified a beneficial gut bacterium that, when restored in animal models, significantly reduced markers of lupus. The findings represent the first potential probiotic approach to treating the disease and open a promising new avenue for research into microbiome-based therapies: https://bit.ly/4aX1dCu

Research led by UT Health San Antonio identified an association between GLP-1 medications and reduced risk across multiple cancers using one of the world's largest real-world clinical databases. The work, presented at the 2026 American Society of Clinical Oncology Annual Meeting, earned physician-scientist Colton Jones, MD, the prestigious Healio NextGen Disruptor Award.

While additional clinical trials are needed to determine whether this association is causal, the findings highlight the potential for widely used therapies to reshape future approaches to cancer prevention and improve outcomes for patients worldwide: https://bit.ly/4f2FKtc